Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case–control study

In March, 2024, Argentina became the first country to implement a national maternal immunisation programme with bivalent respiratory syncytial virus (RSV) prefusion F vaccine (RSVpreF) as the primary strategy to prevent RSV disease among infants. We aimed to evaluate vaccine effectiveness against RS...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases Vol. 25; no. 9; pp. 1044 - 1054
Main Authors: Pérez Marc, Gonzalo, Vizzotti, Carla, Fell, Deshayne B, Di Nunzio, Lucila, Olszevicki, Santiago, Mankiewicz, Shauna Wolf, Braem, Virginia, Rearte, Ramiro, Atwell, Jessica E, Bianchi, Alejandra, Fuentes, Nora, Zadoff, Romina, Vecchio, Gabriela, Gabriela Abalos, María, Fan, Rong, del Carmen Morales, Graciela, Gessner, Bradford D, Jodar, Luis, Libster, Romina, Rearte, Analía
Format: Journal Article
Language:English
Published: United States Elsevier Ltd 01.09.2025
Elsevier Limited
Subjects:
ISSN:1473-3099, 1474-4457, 1474-4457
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first